razoxane has been researched along with Cancer of Rectum in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (83.33) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eiter, H; Hammer, J; Rhomberg, W; Schneider, B; Sedlmayer, F; Seewald, D | 1 |
| Harvey, VJ; Slevin, ML; Wrigley, PF | 1 |
| Ashford, RF; Bakowski, M; Evans, M; Hellman, K; Jones, R; Lambert, J; Newton, K; Peters, N; Phillips, R; Smith, BJ | 1 |
| Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
| Cullinan, S; Everson, L; Gerstner, J; Krook, J; Laurie, J; McCormack, G; Schutt, A; Scott, M; Shreck, R; Windschitl, H | 1 |
| Gilbert, JM; Kark, AE; Slavin, G; Thompson, EM | 1 |
| Kaplan, BH; Lanham, R; Vogl, SE | 1 |
| Cassell, PC; Ellis, H; Evans, MG; Gilbert, JM; Hellmann, K; Stoodley, BJ; Wastell, C | 1 |
| Cassell, PG; Ellis, H; Evans, M; Gilbert, JM; Hellmann, K; Stoodley, B; Wastell, C | 1 |
| Cullinan, SA; Everson, LK; Krook, JE; Scott, M; Windschitl, HE | 1 |
| Eiter, H; Hergan, K; Rhomberg, W; Schneider, B | 1 |
| Bellet, RE; Muggia, FM; Penta, JS; Rozencweig, M; Von Hoff, DD; Wasserman, TH | 1 |
| Bellet, RE; Catalano, RB; Creech, RH; Engstrom, PF; Mastrangelo, MJ | 1 |
| Eiter, H; Rhomberg, W | 2 |
| Douglass, HO; Engstrom, PF; Kaufman, J; Klaassen, D; MacIntyre, JM; Von Hoff, D | 1 |
| Hahn, RG; Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; Scott, M | 1 |
| Cassell, PG; Ellis, H; Evans, M; Gilbert, JM; Hellmann, K; Stoodley, B; Taylor, RH; Wastell, C | 1 |
1 review(s) available for razoxane and Cancer of Rectum
| Article | Year |
|---|---|
[Radio-oncological treatment possibilities in local recurrence of rectal carcinoma. An interdisciplinary comparison].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Neoplasm Recurrence, Local; Piperazines; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Rectal Neoplasms; Survival Analysis | 1990 |
12 trial(s) available for razoxane and Cancer of Rectum
| Article | Year |
|---|---|
Irradiation with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Austria; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Razoxane; Rectal Neoplasms; Treatment Outcome | 2007 |
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Humans; Piperazines; Razoxane; Rectal Neoplasms | 1983 |
A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Piperazines; Prognosis; Razoxane; Rectal Neoplasms; Stomach Neoplasms | 1983 |
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nausea; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Stomatitis; Thrombocytopenia; Triazines; Vomiting | 1983 |
Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Leukopenia; Nausea; Piperazines; Razoxane; Rectal Neoplasms; Thrombocytopenia; Triazines | 1980 |
A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Piperazines; Razoxane; Rectal Neoplasms; Recurrence; Semustine; Vincristine | 1981 |
Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Razoxane; Rectal Neoplasms | 1982 |
Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy; Razoxane; Rectal Neoplasms; Survival Rate | 1994 |
Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Humans; Lomustine; Mesylates; Piperazines; Random Allocation; Razoxane; Rectal Neoplasms | 1985 |
A randomized clinical trial of combination chemotherapy in advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors; Triazines; Vincristine | 1987 |
Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Piperazines; Prospective Studies; Random Allocation; Razoxane; Rectal Neoplasms | 1986 |
5 other study(ies) available for razoxane and Cancer of Rectum
| Article | Year |
|---|---|
Inhibition of experimental colorectal cancer by razoxane (ICRF-159).
Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Carcinogens; Colonic Neoplasms; Dimethylhydrazines; Drug Administration Schedule; Female; Piperazines; Random Allocation; Rats; Rats, Inbred Strains; Razoxane; Rectal Neoplasms | 1984 |
Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Topics: Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Nitrosourea Compounds; Piperazines; Razoxane; Rectal Neoplasms; Semustine; Triazines | 1982 |
ICRF-159: current status and clinical prospects.
Topics: Alopecia; Animals; Colonic Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphoma; Melanoma; Mice; Nausea; Neoplasms, Experimental; Piperazines; Razoxane; Rectal Neoplasms; Sarcoma | 1977 |
Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.
Topics: Adult; Aged; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Razoxane; Rectal Neoplasms | 1976 |
[Radiation sensitivity studies of inoperable and recurrent rectal carcinomas].
Topics: Brachytherapy; Cesium Radioisotopes; Cobalt Radioisotopes; Combined Modality Therapy; Humans; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Radiation Injuries; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotope Teletherapy; Radiotherapy Dosage; Razoxane; Rectal Neoplasms; Remission Induction | 1989 |